Carrie D'Andrea - Jul 14, 2023 Form 4 Insider Report for Acasti Pharma Inc. (ACST)

Role
VP Clinical Operations
Signature
/s/ Prashant Kohli, as attorney-in-fact
Stock symbol
ACST
Transactions as of
Jul 14, 2023
Transactions value $
$0
Form type
4
Date filed
7/18/2023, 04:32 PM
Previous filing
May 18, 2023
Next filing
May 8, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACST Stock Options (Right to Buy) Award $0 +42K $0.00 42K Jul 14, 2023 Class A Common Shares 42K $2.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options granted on 07/14/2023 under the Acasti Pharma Stock Option Plan, which vest and become exercisable in equal quarterly installments over a period of 36 months.